Technology
Health
Biotechnology
Capricor
$5.929876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-1.33%) As of 2:34 PM EDT today
-$0.08 (-1.33%) Today
Why Robinhood?
You can buy or sell Capricor and other stocks, options, ETFs, and crypto commission-free!
About CAPR
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. Read More The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
Employees
22
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
20.20M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
184.80K
High Today
$7.35
Low Today
$5.63
Open Price
$6.33
Volume
3.32M
52 Week High
$14.60
52 Week Low
$2.53
Collections
Technology
Health
Biotechnology
Therapy
Medical
US
North America
Female CEOs
CAPR News
CAPR Earnings
-$0.16
-$0.13
-$0.11
-$0.08
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours